메뉴 건너뛰기




Volumn 5, Issue 3, 2004, Pages 798-813

Anticoagulant and antiplatelet agents: Their clinical and device application(s) together with usages to engineer surfaces

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; BIOMEDICAL EQUIPMENT; CARDIOVASCULAR SYSTEM; MACROMOLECULES;

EID: 2542629648     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm0344553     Document Type: Review
Times cited : (154)

References (192)
  • 27
  • 28
  • 29
    • 0033528281 scopus 로고    scopus 로고
    • Organisation to Assess Strategies for Ischemic Syndromes (OASIS2) Investigators
    • Organisation to Assess Strategies for Ischemic Syndromes (OASIS2) Investigators. Lancet 1999, 353, 429-438.
    • (1999) Lancet , vol.353 , pp. 429-438
  • 38
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials
    • Collaborative meta-analysis of randomised trials. Br. Med. J. 2002, 324, 71-86.
    • (2002) Br. Med. J. , vol.324 , pp. 71-86
  • 65
    • 1842369101 scopus 로고    scopus 로고
    • The EPILOG Investigators
    • The EPILOG Investigators. N. Engl. J. Med. 1997, 336, 1689-1696.
    • (1997) N. Engl. J. Med. , vol.336 , pp. 1689-1696
  • 66
    • 0030919511 scopus 로고    scopus 로고
    • Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II (IMPACT-II)
    • Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II (IMPACT-II). Lancet 1997, 349, 1422-1428.
    • (1997) Lancet , vol.349 , pp. 1422-1428
  • 68
    • 2642654221 scopus 로고    scopus 로고
    • Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
    • Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. N. Engl. J. Med. 1998, 338, 1498-1505.
    • (1998) N. Engl. J. Med. , vol.338 , pp. 1498-1505
  • 69
    • 2642599026 scopus 로고    scopus 로고
    • Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
    • Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. New Engl. J. Med. 1998, 338, 1488-1497.
    • (1998) New Engl. J. Med. , vol.338 , pp. 1488-1497


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.